• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维持性血液透析治疗患者的骨形态学、骨密度测定及实验室数据研究。

Studies of bone morphology, bone densitometry and laboratory data in patients on maintenance hemodialysis treatment.

作者信息

Lindergård B, Johnell O, Nilsson B E, Wiklund P E

出版信息

Nephron. 1985;39(2):122-9. doi: 10.1159/000183355.

DOI:10.1159/000183355
PMID:3974774
Abstract

Bone morphological parameters of renal osteodystrophy such as abundance of osteoid surface, osteoid seam width index, calcification fronts, osteoclast activity and trabecular bone volume were studied in 71 patients on maintenance hemodialysis and compared with bone densitometry, laboratory and clinical data. Increased osteoclast activity (hyperparathyroidism) was by far the most common bone morphological finding. Patients with chronic pyelonephritis or polycystic kidney disease had more than double the amount of osteoid than patients with chronic glomerulonephritis. The trabecular bone volume seemed to be increased in most patients in contrast to the cortical bone volume which was decreased, judged from bone densitometry and previously from X-ray. Despite that patients with polycystic kidney disease were older, their trabecular volume was larger than in patients with glomerulonephritis. The bone mineral content evaluated by bone densitometry was low in most patients, and more associated with bone morphological signs of osteomalacia than with secondary hyperparathyroidism. Serum phosphate (S-PO4) and serum parathyroid hormone (S-PTH) seemed to discriminate better between osteomalacia and secondary hyperparathyroidism than serum alkaline phosphatase (S-Alk. phosph.), which was elevated in both groups. Patients who had been bilaterally nephrectomized were no more abnormal than other patients, and they had lower S-Alk. phosph. The abundance of osteoclasts was found to be a predictor of future development of clinical secondary hyperparathyroidism.

摘要

对71例维持性血液透析患者的肾性骨营养不良的骨形态学参数进行了研究,如类骨质表面丰度、类骨质缝宽度指数、钙化前沿、破骨细胞活性和小梁骨体积,并与骨密度测定、实验室及临床数据进行了比较。破骨细胞活性增加(甲状旁腺功能亢进)是迄今为止最常见的骨形态学表现。慢性肾盂肾炎或多囊肾病患者的类骨质量是慢性肾小球肾炎患者的两倍多。根据骨密度测定以及之前的X线检查判断,大多数患者的小梁骨体积似乎增加,而皮质骨体积减少。尽管多囊肾病患者年龄较大,但他们的小梁骨体积比肾小球肾炎患者的大。大多数患者通过骨密度测定评估的骨矿物质含量较低,且更多地与骨软化的骨形态学体征相关,而非与继发性甲状旁腺功能亢进相关。血清磷酸盐(S-PO4)和血清甲状旁腺激素(S-PTH)在区分骨软化和继发性甲状旁腺功能亢进方面似乎比血清碱性磷酸酶(S-碱性磷酸酶)更好,后者在两组中均升高。双侧肾切除的患者并不比其他患者更异常,且他们的S-碱性磷酸酶较低。发现破骨细胞丰度是临床继发性甲状旁腺功能亢进未来发展的一个预测指标。

相似文献

1
Studies of bone morphology, bone densitometry and laboratory data in patients on maintenance hemodialysis treatment.维持性血液透析治疗患者的骨形态学、骨密度测定及实验室数据研究。
Nephron. 1985;39(2):122-9. doi: 10.1159/000183355.
2
Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.肝素钠对慢性肾脏病大鼠肾性骨营养不良和血管钙化的影响。
Bone. 2014 Jan;58:168-76. doi: 10.1016/j.bone.2013.10.010. Epub 2013 Oct 18.
3
Can bone histomorphometry be predicted by clinical assessment and noninvasive techniques in peritoneal dialysis?腹膜透析中骨组织形态计量学能否通过临床评估和非侵入性技术进行预测?
Miner Electrolyte Metab. 1996;22(4):224-33.
4
Decreased mineralization in hemodialysis patients after subtotal parathyroidectomy.甲状旁腺次全切除术后血液透析患者骨矿化减少。
Calcif Tissue Int. 1982 Jan;34(1):16-20. doi: 10.1007/BF02411202.
5
Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.透析患者肾性骨营养不良的评估:骨碱性磷酸酶、骨密度和甲状旁腺超声与骨组织学的比较应用
Nephron. 1997;75(4):412-9. doi: 10.1159/000189578.
6
The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.57例慢性血液透析患者肾性骨营养不良的临床谱:生化参数与骨病理结果的相关性
Clin Nephrol. 1991 Feb;35(2):78-85.
7
Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.透析前及血液透析患者的肾性骨营养不良:组织学模式及完整甲状旁腺激素诊断预测性的比较
Nephron. 2002 May;91(1):103-11. doi: 10.1159/000057611.
8
[Renal osteodystrophy in patients on maintenance hemodialysis: statistical study of clinical, radiological and biochemical features].维持性血液透析患者的肾性骨营养不良:临床、放射学及生化特征的统计学研究
Schweiz Med Wochenschr. 1981 Jan 31;111(5):154-6.
9
Bone disease in renal failure. Clinical and histomorphometric studies.
Scand J Urol Nephrol Suppl. 1984;84:1-68.
10
Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.骨转换率低与非低的血液透析患者的骨碱性磷酸酶同工型:一项诊断试验研究
Am J Kidney Dis. 2015 Jul;66(1):99-105. doi: 10.1053/j.ajkd.2015.02.323. Epub 2015 Apr 2.

引用本文的文献

1
Skeletal and mineral metabolic effects of risedronate in a rat model of high-turnover renal osteodystrophy.利塞膦酸钠对高转换型肾性骨营养不良大鼠模型的骨骼和矿物质代谢的影响。
J Bone Miner Metab. 2020 Jul;38(4):501-510. doi: 10.1007/s00774-020-01095-0. Epub 2020 Mar 5.
2
Update on the role of bone biopsy in the management of patients with CKD-MBD.慢性肾脏病-矿物质和骨代谢异常患者骨活检在管理中的作用更新。
J Nephrol. 2017 Oct;30(5):645-652. doi: 10.1007/s40620-017-0424-8. Epub 2017 Aug 22.
3
Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study.
血清骨保护素水平与慢性肾脏病骨丢失的关联:来自慢性肾脏病知晓研究的见解
PLoS One. 2016 Nov 17;11(11):e0166792. doi: 10.1371/journal.pone.0166792. eCollection 2016.
4
Physiological mechanisms and therapeutic potential of bone mechanosensing.骨力感受的生理机制及治疗潜力
Rev Endocr Metab Disord. 2015 Jun;16(2):115-29. doi: 10.1007/s11154-015-9313-4.
5
Vitamin D and UV exposure in chronic kidney disease.慢性肾脏病中的维生素D与紫外线暴露
Dermatoendocrinol. 2013 Jan 1;5(1):109-16. doi: 10.4161/derm.24539.
6
Renale osteodystrophie.肾性骨营养不良
Wien Med Wochenschr. 2013 Sep;163(17-18):403-8. doi: 10.1007/s10354-013-0195-3. Epub 2013 May 9.
7
The high prevalence of chronic kidney disease-mineral bone disorders: A hospital-based cross-sectional study.慢性肾脏病-矿物质和骨异常的高患病率:一项基于医院的横断面研究。
Indian J Nephrol. 2012 Jul;22(4):285-91. doi: 10.4103/0971-4065.101249.
8
Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients.维持性血液透析患者血清碱性磷酸酶与骨矿物质密度的相关性
Hemodial Int. 2010 Apr;14(2):182-92. doi: 10.1111/j.1542-4758.2009.00430.x. Epub 2010 Mar 24.
9
Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients.血液透析患者的股骨骨密度反映了组织学确定的皮质骨体积。
Osteoporos Int. 2010 Apr;21(4):619-25. doi: 10.1007/s00198-009-0988-9. Epub 2009 Jun 25.
10
Chronic kidney disease and bone fracture: a growing concern.慢性肾病与骨折:日益受到关注。
Kidney Int. 2008 Sep;74(6):721-31. doi: 10.1038/ki.2008.264. Epub 2008 Jun 18.